Raras
Buscar doenças, sintomas, genes...
Albinismo oculocutâneo tipo 2
ORPHA:79432CID-10 · E70.3CID-11 · EC23.20OMIM 203200DOENÇA RARA

O albinismo oculocutâneo tipo 2 (OCA2) é um tipo de albinismo oculocutâneo (OCA) e a forma mais comum observada na população africana. Ele é caracterizado por pouca ou nenhuma pigmentação (cor) na pele e nos cabelos, em graus variados, por várias alterações típicas nos olhos e por um direcionamento incorreto dos nervos ópticos no quiasma (o ponto onde os nervos dos olhos se cruzam).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

O albinismo oculocutâneo tipo 2 (OCA2) é um tipo de albinismo oculocutâneo (OCA) e a forma mais comum observada na população africana. Ele é caracterizado por pouca ou nenhuma pigmentação (cor) na pele e nos cabelos, em graus variados, por várias alterações típicas nos olhos e por um direcionamento incorreto dos nervos ópticos no quiasma (o ponto onde os nervos dos olhos se cruzam).

Publicações científicas
45 artigos
Último publicado: 2025 Jun

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
58.34
Specific population
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E70.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (6)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
13 sintomas
🧬
Pele e cabelo
9 sintomas

+ 11 sintomas em outras categorias

Características mais comuns

55%prev.
Íris azuis
Frequente (79-30%)
55%prev.
Acuidade visual reduzida
Frequente (79-30%)
55%prev.
Anormalidade da refração
Frequente (79-30%)
55%prev.
Desvio do nervo óptico
Frequente (79-30%)
55%prev.
Hipopigmentação da pele
Frequente (79-30%)
55%prev.
Cabelo branco
Frequente (79-30%)
33sintomas
Frequente (17)
Ocasional (6)
Muito raro (1)
Sem dados (9)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 33 características clínicas mais associadas, ordenadas por frequência.

Íris azuisBlue irides
Frequente (79-30%)55%
Acuidade visual reduzidaReduced visual acuity
Frequente (79-30%)55%
Anormalidade da refraçãoAbnormality of refraction
Frequente (79-30%)55%
Desvio do nervo ópticoOptic nerve misrouting
Frequente (79-30%)55%
Hipopigmentação da peleHypopigmentation of the skin
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico45PubMed
Últimos 10 anos56publicações
Pico202311 papers
Linha do tempo
2025Hoje · 2026🧪 2018Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

OCA2P proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Contributes to a melanosome-specific anion (chloride) current that modulates melanosomal pH for optimal tyrosinase activity required for melanogenesis and the melanosome maturation (PubMed:11310796, PubMed:15262401, PubMed:22234890, PubMed:25513726). One of the components of the mammalian pigmentary system (PubMed:15262401, PubMed:18252222, PubMed:7601462). May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color (PubMe

LOCALIZAÇÃO

Melanosome membrane

VIAS BIOLÓGICAS (1)
Melanin biosynthesis
MECANISMO DE DOENÇA

Albinism, oculocutaneous, 2

An autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in skin, hair, and eyes. Although affected infants may appear at birth to have complete absence of melanin pigment, most patients acquire small amounts of pigment with age. Visual anomalies include decreased acuity and nystagmus. The phenotype is highly variable. The hair of affected individuals may turn darker with age, and pigmented nevi or freckles may be seen. African and African American individuals may have yellow hair and blue-gray or hazel irides. One phenotypic variant, 'brown OCA,' has been described in African and African American populations and is characterized by light brown hair and skin color and gray to tan irides.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Artéria tibial
10.5 TPM
Tireoide
9.2 TPM
Aorta
8.2 TPM
Skin Sun Exposed Lower leg
7.1 TPM
Testículo
5.3 TPM
OUTRAS DOENÇAS (6)
obsolete skin/hair/eye pigmentation, variation in, 1oculocutaneous albinism type 2Angelman syndrome due to maternal 15q11q13 deletionPrader-Willi syndrome due to maternal uniparental disomy of chromosome 15
HGNC:8101UniProt:Q04671
MC1RMelanocyte-stimulating hormone receptorModifying germline mutation inDesconhecido
FUNÇÃO

G protein-coupled receptor that binds melanocyte-stimulating hormones (alpha, beta, and gamma-MSH) and adrenocorticotropic hormone/ACTH, which are peptide products of the POMC precursor protein (PubMed:11442765, PubMed:11707265, PubMed:1325670, PubMed:1516719, PubMed:8463333). Upon activation, MC1R couples with the G(s) protein, stimulating adenylate cyclase and activating the cAMP-dependent signaling pathway. This activation promotes melanogenesis, resulting in the production of eumelanin (blac

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
G alpha (s) signalling eventsPeptide ligand-binding receptorsTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Melanoma, cutaneous malignant 5

A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but may also involve other sites.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
53.9 TPM
Pituitária
34.8 TPM
Cerebelo
32.6 TPM
Cérebro - Hemisfério cerebelar
29.1 TPM
Tireoide
26.9 TPM
OUTRAS DOENÇAS (4)
obsolete skin/hair/eye pigmentation, variation in, 2familial melanomaoculocutaneous albinism type 2melanoma, cutaneous malignant, susceptibility to, 5
HGNC:6929UniProt:Q01726

Variantes genéticas (ClinVar)

845 variantes patogênicas registradas no ClinVar.

🧬 MC1R: GRCh37/hg19 16q11.2-24.3(chr16:46432879-90294753)x3 ()
🧬 MC1R: NM_002386.4(MC1R):c.908delinsTCC (p.Gln303fs) ()
🧬 MC1R: Single allele ()
🧬 MC1R: NC_000016.9:g.(?_89874682)_(90002212_?)del ()
🧬 MC1R: NC_000016.9:g.(?_89865554)_(90109753_?)del ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 924 variantes classificadas pelo ClinVar.

739
185
Patogênica (80.0%)
VUS (20.0%)
VARIANTES MAIS SIGNIFICATIVAS
OCA2: NM_000275.3(OCA2):c.2338G>A (p.Gly780Ser) [Likely pathogenic]
TYR: NM_000372.5(TYR):c.605A>T (p.His202Leu) [Likely pathogenic]
SLC45A2: NM_016180.5(SLC45A2):c.1238G>A (p.Gly413Glu) [Likely pathogenic]
OCA2: NM_000275.3(OCA2):c.2063T>C (p.Leu688Pro) [Pathogenic]
TYR: NM_000372.5(TYR):c.265del (p.Cys89fs) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Albinismo oculocutâneo tipo 2

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
12 papers (10 anos)
#1

Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2.

Frontiers in pediatrics2025

Oculocutaneous albinism (OCA) is a condition inherited in an autosomal recessive manner, leading to reduced pigmentation in the skin, hair, and eyes. Oculocutaneous albinism type 2 (OCA2) is one of the most common forms of OCA, caused by OCA2 mutations. This case report presents a newborn with suspected OCA. Postnatal examination revealed white skin, golden-colored hair, and reduced visibility of the retinal pigmented epithelium on fundus photography. Genomic DNA was extracted from the peripheral blood of the patient and her parents. Whole Exome Sequencing (WES) was conducted using chip capture-based high-throughput sequencing technology to analyze genomic DNA from the proband and her parents. Genetic variants of his parents were identified using sanger sequencing. A mutation in the OCA2 was identified: NM_000275.2: c.863_886delTGAGCAGGACCTTTGAGGTGA (p.Met288_Leu295del). Subsequently genetic analyses were conducted. This mutation was recognized as a potential disease-causing mutation, validating diagnosis of OCA2. Currently, few reports have been published regarding this mutation site. It represents a new mutation site in OCA2 (NM_000275.2:c.863_886del), contributing to the genetic diversity of the OCA2.

#2

Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays.

Pigment cell &amp; melanoma research2025 Jan

Oculocutaneous albinism type 2 (OCA-2, OMIM: 203200) is associated with variants in the OCA2 gene. In this study, we aimed to re-classify variants of uncertain significance (VUS) in OCA2 by evaluating subcellular localization and channel activity through multiplex assays of variant effect (MAVEs). Following the ClinGen guidelines for PS3 evidence, we selected 13 OCA2 variants from ClinVar (6 benign/likely benign [B/LB] and 7 pathogenic/likely pathogenic [P/LP]) for OddsPath analysis. The P/LP variants exhibited abnormal functions, while the B/LB variants demonstrated normal functions, supporting the application of "PS3_moderate" evidence for VUS re-classification. In our functional evaluation of 30 VUS identified in 38 individuals with suspected OCA-2 by trio whole-exome sequencing, we observed 6 VUS with abnormal localization and 11 with abnormal channel activity. Based on PS3_moderate evidence, 8 VUS were re-classified as LP, while 22 remained VUS. Consequently, 7 out of 38 previously undiagnosed patients received a molecular diagnosis of OCA-2. These MAVEs offer a robust approach for curating OCA2 VUS, enhancing diagnostic accuracy, and informing genetic counseling. Additionally, this variant cohort is a valuable resource for public databases.

#3

Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights.

Asian biomedicine : research, reviews and news2025 Jun

Albinism is a rare genetic condition characterized by hypopigmentation of the skin, hair, and eyes, as well as visual impairments. Oculocutaneous albinism type 2 (OCA2) is commonly associated with variants in the OCA2 gene, which encodes a protein critical for melanosomal pH regulation and melanin biosynthesis. Exome sequencing, validated by Sanger sequencing, was employed to investigate the genetic basis of albinism in a consanguineous Iranian family. Bioinformatics analyses and structural modeling were conducted to assess the pathogenicity and impact of the detected variant. A 27-year-old male from a consanguineous Iranian family presented with features of oculocutaneous albinism, including white hair, blue eyes, strabismus, sun-sensitive skin, reduced visual acuity, and significant photophobia, resulting in functional limitations in bright environments. Genetic analysis identified a novel homozygous missense variant in the OCA2 gene, NM_000275.3:c.1274T>G (p.Met425Arg), located in exon 13. The genomic coordinates of the variant are chr15:g.27985154A>C (GRCh38/hg38). In silico tools classified the variant as likely pathogenic based on its evolutionary conservation, absence in population databases, and structural modeling predictions. Segregation analysis confirmed autosomal recessive inheritance, with both parents being heterozygous carriers. The identified OCA2 variant, c.1274T>G; p.Met425Arg, disrupts protein function, impairing melanosomal activity and melanin biosynthesis. This study underscores the importance of genetic analysis in characterizing OCA2 variants and highlights the need for further exploration of molecular mechanisms and phenotypic variability in OCA2-related albinism to improve diagnosis and counseling.

#4

Identification of Candidate Genes for Red-Eyed (Albinism) Domestic Guppies Using Genomic and Transcriptomic Analyses.

International journal of molecular sciences2024 Feb 11

Guppies are small tropical fish with brightly colored bodies and variable tail shapes. There are two phenotypes of domestic guppy eye color: red and black. The wild type is black-eyed. The main object of this study was to identify candidate genes for the red-eyed phenotype in domestic guppies. We hope to provide molecular genetic information for the development of new domestic guppy strains. Additionally, the results also contribute to basic research concerning guppies. In this study, 121 domestic guppies were used for genomic analysis (GWAS), and 44 genes were identified. Furthermore, 21 domestic guppies were used for transcriptomic analysis, and 874 differentially expressed genes (DEGs) were identified, including 357 upregulated and 517 downregulated genes. Through GO and KEGG enrichment, we identified some important terms or pathways mainly related to melanin biosynthesis and ion transport. qRT-PCR was also performed to verify the differential expression levels of four important candidate genes (TYR, OCA2, SLC45A2, and SLC24A5) between red-eyed and black-eyed guppies. Based on the results of genomic and transcriptomic analyses, we propose that OCA2 is the most important candidate gene for the red-eyed phenotype in guppies.

#5

Visual acuity improvement in children with albinism beyond the first decade of life.

PloS one2024

To determine if visual maturation continues beyond the first decade of life in children with albinism and whether this is related to albinism type, presence of nystagmus, eye muscle surgery or refractive errors. Case series based on retrospective study of children with confirmed genetic diagnosis of albinism. Clinical data were obtained from medical files of children examined during school years, including albinism type, visual acuity, eye muscle surgery, nystagmus, and others on different visits (Visit 1: ages 7-9; Visit 2: ages: 10-12; Visit 3: ages 13-16; Visit 4: ages >16). Seventy-five children with albinism were included in the study. Patients were divided into different groups according to the albinism type including OCA1A: 17; OCA1B: 28; OCA2: 26; HPS: 3; OCA4: 1. Follow-up ranged from 3-13 years. Progressive visual acuity improvement was seen in all three main groups. T-test paired samples showed a statistically significant improvement when comparing vision from Visit 1 and Visit 3 in both OCA1A and OCA2 groups, with a mean vision improvement of 2 lines. There was no correlation between visual improvement and refractive error, eye muscle surgery or nystagmus. An improved visual performance was seen in a large percentage of children with albinism during the second decade of life. The reason for this late improvement in vision is not clear but may be related to late foveal maturation or improvement in nystagmus with time. This information is useful for clinicians of these patients and when counseling parents.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC618 artigos no totalmostrando 56

2025

Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights.

Asian biomedicine : research, reviews and news
2025

Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2.

Frontiers in pediatrics
2025

Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays.

Pigment cell &amp; melanoma research
2024

Runs of Homozygosity Detection and Selection Signature Analysis for Local Goat Breeds in Yunnan, China.

Genes
2024

Identification of Candidate Genes for Red-Eyed (Albinism) Domestic Guppies Using Genomic and Transcriptomic Analyses.

International journal of molecular sciences
2024

Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family.

Hereditas
2024

Visual acuity improvement in children with albinism beyond the first decade of life.

PloS one
2024

Integrative functional genomic analyses identify genetic variants influencing skin pigmentation in Africans.

Nature genetics
2024

Genetic landscape of forensic DNA phenotyping markers among Mediterranean populations.

Forensic science international
2024

Comparative transcriptome analysis reveals growth and molecular pathway of body color regulation in turbot (Scophthalmus maximus) exposed to different light spectrum.

Comparative biochemistry and physiology. Part D, Genomics &amp; proteomics
2024

Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families.

Gene
2024

Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism.

Molecular genetics &amp; genomic medicine
2023

Ophthalmologic Phenotype-Genotype Correlations in Patients With Oculocutaneous Albinism Followed in a Reference Center.

Investigative ophthalmology &amp; visual science
2024

Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism.

Pigment cell &amp; melanoma research
2023

Forensic DNA Phenotyping: Genes and Genetic Variants for Eye Color Prediction.

Genes
2023

Black Piedra in an Amerindian Girl with Oculocutaneous Albinism Type 2.

Dermatology practical &amp; conceptual
2023

Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.

Alternative therapies in health and medicine
2023

Structural insights into pink-eyed dilution protein (Oca2).

Bioscience reports
2023

Association between Variants in the OCA2-HERC2 Region and Blue Eye Colour in HERC2 rs12913832 AA and AG Individuals.

Genes
2023

Identification of novel variations of oculocutaneous albinism type 2 with Prader-Willi syndrome/Angelman syndrome in two Chinese families.

Frontiers in genetics
2023

[Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2023

Concurrent PANK2 and OCA2 variants in a patient with retinal dystrophy, hypopigmented irides and neurodegeneration.

Ophthalmic genetics
2023

Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.

Ophthalmic genetics
2022

Molecular genetic characterization of Congolese patients with oculocutaneous albinism.

European journal of medical genetics
2022

Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.

Frontiers in immunology
2022

Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo.

European journal of medical genetics
2022

QTL Mapping for Age-Related Eye Pigmentation in the Pink-Eyed Dilution Castaneus Mutant Mouse.

Genes
2022

Genetic analyses of Vietnamese patients with oculocutaneous albinism.

Journal of clinical laboratory analysis
2022

Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.

Genes
2022

Axial Length Distributions in Patients With Genetically Confirmed Inherited Retinal Diseases.

Investigative ophthalmology &amp; visual science
2022

NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.

BMC genomics
2023

Abnormal foveal morphology in carriers of oculocutaneous albinism.

The British journal of ophthalmology
2022

Delineating Novel and Known Pathogenic Variants in TYR, OCA2 and HPS-1 Genes in Eight Oculocutaneous Albinism (OCA) Pakistani Families.

Genes
2021

A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus.

Human mutation
2022

Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2020

Intravitreal administration of small molecule read-through agents demonstrate functional activity in a nonsense mutation mouse model.

Experimental eye research
2020

The distinctive geographic patterns of common pigmentation variants at the OCA2 gene.

Scientific reports
2019

[Analysis of P gene variations among fourteen patients with oculocutaneous albinism type II].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2019

Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.

BMC medical genetics
2019

Genome of the Malawi golden cichlid fish (Melanochromis auratus) reveals exon loss of oca2 in an amelanistic morph.

Pigment cell &amp; melanoma research
2019

Effects of silica-rich water on systemic and peritoneal inflammation in rats exposed to chronic low-level (900-MHz) microwave radiation.

General physiology and biophysics
2018

Behavioural changes controlled by catecholaminergic systems explain recurrent loss of pigmentation in cavefish.

Proceedings. Biological sciences
2017

Mutational analysis of a Chinese family with oculocutaneous albinism type 2.

Oncotarget
2017

OCA2 splice site variant in German Spitz dogs with oculocutaneous albinism.

PloS one
2017

Protective effect of geraniin against carbon tetrachloride induced acute hepatotoxicity in Swiss albino mice.

Biochemical and biophysical research communications
2017

Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats.

Biomaterials
2017

Associations of OCA2-HERC2 SNPs and haplotypes with human pigmentation characteristics in the Brazilian population.

Legal medicine (Tokyo, Japan)
2016

A cross-sectional examination of visual acuity by specific type of albinism.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2015

Posterior staphyloma in oculocutaneous albinism: another possible cause of reduced visual acuity.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2016

Genetic analyses of oculocutaneous albinism types 2 and 4 with eight novel mutations.

Journal of dermatological science
2015

l-tyrosine induces melanocyte differentiation in novel pink-eyed dilution castaneus mouse mutant showing age-related pigmentation.

Journal of dermatological science
2015

Cytoplasmic Control of Sense-Antisense mRNA Pairs.

Cell reports
2015

Association study confirms the role of two OCA2 polymorphisms in normal skin pigmentation variation in East Asian populations.

American journal of human biology : the official journal of the Human Biology Council
2015

Genome editing using TALENs in blind Mexican Cavefish, Astyanax mexicanus.

PloS one
2015

A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice.

Experimental animals
2015

Refractive errors, visual impairment, and the use of low-vision devices in albinism in Malawi.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Ver todos os 618 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Albinismo oculocutâneo tipo 2.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Albinismo oculocutâneo tipo 2

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Case Report: Genetic analysis of oculocutaneous albinism type 2 caused by a new mutation in the OCA2.
    Frontiers in pediatrics· 2025· PMID 40313672mais citado
  2. Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays.
    Pigment cell &amp; melanoma research· 2025· PMID 39636647mais citado
  3. Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights.
    Asian biomedicine : research, reviews and news· 2025· PMID 40735666mais citado
  4. Identification of Candidate Genes for Red-Eyed (Albinism) Domestic Guppies Using Genomic and Transcriptomic Analyses.
    International journal of molecular sciences· 2024· PMID 38396851mais citado
  5. Visual acuity improvement in children with albinism beyond the first decade of life.
    PloS one· 2024· PMID 38232104mais citado
  6. Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism.
    Pigment Cell Melanoma Res· 2024· PMID 37650133recente
  7. Black Piedra in an Amerindian Girl with Oculocutaneous Albinism Type 2.
    Dermatol Pract Concept· 2023· PMID 37557120recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79432(Orphanet)
  2. OMIM OMIM:203200(OMIM)
  3. MONDO:0008746(MONDO)
  4. GARD:4038(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q2017745(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Albinismo oculocutâneo tipo 2
Compêndio · Raras BR

Albinismo oculocutâneo tipo 2

ORPHA:79432 · MONDO:0008746
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
CID-10
E70.3 · Albinismo
CID-11
Início
Infancy, Neonatal
Prevalência
58.34 (Specific population)
MedGen
UMLS
C0268495
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades